In mouse meningeal nerve preparations, anandamide (AEA) produced stronger and longer-lasting suppression of pain-related nerve firing than 2-AG, suggesting FAAH inhibitors may be a promising migraine target.
Neuroscience researchers studying migraine mechanisms and pharmaceutical developers targeting the endocannabinoid system.
AEA suppressed high-amplitude nerve fibers firing above 10 Hz
What the researchers found
AEA reduced meningeal nerve firing more profoundly and for longer than 2-AG. AEA briefly activated slow-firing fibers (1-2 Hz), then persistently suppressed fast-firing fibers (>10 Hz). Only AEA inhibited subsequent capsaicin-induced firing. Mouse meninges showed higher FAAH activity and lower endogenous AEA levels.
Why it matters
This study provides mechanistic evidence that boosting AEA through FAAH inhibition could reduce migraine-related nerve activation, offering a specific target rather than broad cannabinoid receptor activation.
The numbers in context
AEA suppressed fibers firing >10 Hz; briefly activated fibers at 1-2 Hz; endogenous AEA levels lower than 2-AG; FAAH activity higher than MAGL in meninges.
How the study worked
Ex vivo electrophysiological recordings from C57BL/6J mouse hemiskull preparations. 10 uM AEA or 2-AG applied with 50 mM KCl stimulation. Clustering and spectral analysis. LC-MS/MS measured endogenous enzyme activity and endocannabinoid levels.
What this study cannot tell us
Ex vivo mouse preparation. Single concentrations tested. Results may not translate to human meningeal physiology. Does not test FAAH inhibitors directly.
How to read the evidence
Rigorous ex vivo methodology with multiple analytical approaches, but animal tissue study without in vivo validation.
When this study was published
2025 study presenting novel mechanistic data on endocannabinoids and meningeal pain signaling.
The bigger picture
This study narrows the endocannabinoid focus to AEA and FAAH specifically for migraine, suggesting peripheral FAAH inhibition as a strategy that could avoid central side effects.
Questions still open
- Would FAAH inhibitors reduce migraine frequency in clinical trials?
- Do these AEA effects translate to human tissue?
Common questions
Could endocannabinoids treat migraines?
What is the difference between AEA and 2-AG?
Read the original research
Differential inhibitory effects of endocannabinoids on neuronal firing of mouse meningeal afferents.
The journal of headache and pain, 26(1), 112
Citation
Krivoshein, Georgii; Della Pietra, Adriana; Savinainen, Juha; van den Maagdenberg, Arn M J M; Giniatullin, Rashid. (2025). Differential inhibitory effects of endocannabinoids on neuronal firing of mouse meningeal afferents.. The journal of headache and pain, 26(1), 112. https://doi.org/10.1186/s10194-025-02041-z
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)